LivaNova (LIVN) Interest Coverage Ratio (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | LivaNova | 4.03 Bn | 3.45 Bn | 243.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.54% |
| Dec 31, 2025 | -21.13% |
| Sep 30, 2025 | 12.69% |
| Jun 30, 2025 | 38.73% |
| Mar 31, 2025 | 35.46% |
| Dec 31, 2024 | 4.67% |
| Sep 30, 2024 | -13.26% |
| Jun 30, 2024 | 152.98% |
| Mar 31, 2024 | 118.15% |
| Dec 31, 2023 | -1,993.52% |
| Sep 30, 2023 | -74.65% |
| Jun 30, 2023 | 773.19% |
| Mar 31, 2023 | -116.68% |
| Dec 31, 2022 | 110.02% |
| Sep 30, 2022 | -572.27% |
| Jun 30, 2022 | 82.05% |
| Mar 31, 2022 | -68.92% |
| Dec 31, 2021 | 169.76% |
| Sep 30, 2021 | 165.87% |
| Jun 30, 2021 | -514.09% |
| Mar 31, 2021 | 97.76% |
| Dec 31, 2020 | -3,001.50% |
| Sep 30, 2020 | 82.43% |
| Jun 30, 2020 | -2,345.08% |
| Mar 31, 2020 | 99.62% |
| Dec 31, 2019 | -679.91% |
| Sep 30, 2019 | 173.22% |
| Jun 30, 2019 | 41.06% |
| Mar 31, 2019 | 90.62% |
| Dec 31, 2018 | -5,993.35% |
| Sep 30, 2018 | -130.42% |
| Jun 30, 2018 | 21.10% |
| Mar 31, 2018 | -22.20% |
| Dec 31, 2017 | -63.89% |
| Sep 30, 2017 | 20.03% |
| Jun 30, 2017 | 106.35% |
| Mar 31, 2017 | 326.57% |
| Dec 31, 2016 | -143.32% |
| Sep 30, 2016 | -31.29% |
| Jun 30, 2016 | 266.16% |
| Oct 18, 2015 | -121.81% |
| Jul 24, 2015 | -59.54% |